Melbourne-based biotech company Dimerix Ltd [ASX:DXB] got a shot in the arm recently after being awarded $1 million from the Australian government’s Medical Research Future Fund. This has pushed the DXB share price up 7.14% to trade at 75 cents at the time of writing…
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
GDP Falls 7% as Aussie Economy Is Hit and Yet Small-Caps Are Booming
The economy has been ‘savaged’ according to Prime Minister Scott Morrison. Confirming the news that we all knew was coming. Australia has now officially recorded its first technical recession in 29 years…
Starpharma Share Price Retracing after New COVID-19 Product (ASX:SPL)
The market reacted positively to the Starpharma Holdings Ltd [ASX:SPL] announcement and pushed the share price up to trade at $1.70 yesterday. The SPL share price is retracing now, down 7.35%, trading at $1.57…
Respiri Share Price Lifts on Positive Clinical Study (ASX:RSH)
The share price of medical technology company Respiri Ltd [ASX:RSH] has pushed higher today thanks to positive results from its latest clinical study. At the time of writing, RSH shares had pushed 3.23% higher to trade at 1.6 cents…
Respiri Doubles Revenue for FY20 — RSH Share Price Rises 3.7%
It’s been a mixed year for Respiri Ltd [ASX:RSH]. With markets gripped by the COVID-19 pandemic, shares in the company took a hit. But that didn’t stop the ongoing development of their respiratory monitoring device: wheezo…
Why Australian Vaccine News Will Be Met with a Shrug from the ASX
It’s a strange one, as I write this, ASX 200 futures are pointing to a down day for the index. This, as promising news emerges from the University of Queensland’s (UQ) COVID-19 vaccine project. Here’s what you should know about the Australian vaccine..
